Cardiovascular diseases are a major cause of death in the world. It is estimated that 17.9 million people died from cardiovascular diseases in 2016, representing 31% of all global deaths.1 This makes it the leading cause of death worldwide. Coronary heart disease and stroke are the most common forms of cardiovascular disease, and they account for 85% of all cardiovascular-related deaths.2 Clopidogrel is a novel treatment for cardiovascular disease that has been used for over two decades. It is an antiplatelet drug that helps to prevent blood clots from forming in the arteries, which can lead to heart attack or stroke. It works by inhibiting the activity of platelets, which are cells in the blood that help to form clots.3 Clopidogrel is used to reduce the risk of heart attack and stroke in people with existing cardiovascular disease, as well as to prevent the recurrence of these events in people who have already had a heart attack or stroke. It is also used to prevent the formation of blood clots in people who have had a stent placed in their artery.4
Clopidogrel works by inhibiting the activity of platelets, which are cells in the blood that help to form clots. It does this by blocking a specific receptor on the platelets, called the P2Y12 receptor. This prevents the platelets from sticking together and forming clots.5 Clopidogrel is usually taken in the form of a pill once a day. It is important to take the medication as prescribed by your doctor, as missing doses can reduce its effectiveness. It is also important to take it with food, as this can help to reduce the risk of stomach upset.6
Clopidogrel has been shown to be effective in reducing the risk of heart attack and stroke in people with existing cardiovascular disease, as well as in preventing the recurrence of these events in people who have already had a heart attack or stroke. It has also been shown to reduce the risk of blood clots in people who have had a stent placed in their artery.7 Clopidogrel is also generally well-tolerated, with most people experiencing few side effects. The most common side effects include nausea, diarrhea, and headache. These side effects are usually mild and can be managed with over-the-counter medications.8
Although clopidogrel is generally safe and well-tolerated, there are some risks associated with its use. The most serious risk is an increased risk of bleeding, which can be life-threatening. People who take clopidogrel should be aware of this risk and should talk to their doctor if they experience any signs of bleeding, such as unusual bruising or bleeding from the gums.9 In addition, clopidogrel can interact with other medications, such as warfarin, aspirin, and non-steroidal anti-inflammatory drugs (NSAIDs). It is important to tell your doctor about all medications you are taking before starting clopidogrel.10
Clopidogrel is a novel treatment for cardiovascular disease that has been used for over two decades. It is an antiplatelet drug that helps to prevent blood clots from forming in the arteries, which can lead to heart attack or stroke. It is usually taken in the form of a pill once a day and is generally well-tolerated, with most people experiencing few side effects. Clopidogrel has been shown to be effective in reducing the risk of heart attack and stroke in people with existing cardiovascular disease, as well as in preventing the recurrence of these events in people who have already had a heart attack or stroke. It has also been shown to reduce the risk of blood clots in people who have had a stent placed in their artery. However, there are some risks associated with clopidogrel, including an increased risk of bleeding and potential interactions with other medications. It is important to talk to your doctor before starting clopidogrel to ensure it is the right treatment for you.
1.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
2.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
3.
Research finds stark disparities in treatment and survival time for people with pancreatic cancer
4.
Tumor characteristics found to differ for melanomas in children, teens and young adults
5.
Relationship-building key to addressing oncologist shortages in rural care
1.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
2.
Colon cancer: Risk factors, warning signs and treatment options
3.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
4.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation